MPCI

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562601

CAS#: 884538-31-2

Description: MPCI is a selective antagonist of melanocortin-4 receptor (MC4R).

Chemical Structure

img
MPCI
CAS# 884538-31-2
Instruction

Theoretical Analysis

MedKoo Cat#: 562601
Name: MPCI
CAS#: 884538-31-2
Chemical Formula: C25H32BrFN4O2
Exact Mass: 518.16
Molecular Weight: 519.450
Elemental Analysis: C, 57.81; H, 6.21; Br, 15.38; F, 3.66; N, 10.79; O, 6.16

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: MPCI;

IUPAC/Chemical Name: 2-(5-Bromo-2-methoxyphenethyl)-N-(N-((1-ethylpiperidin-4-yl)methyl)carbamimidoyl)-3-fluorobenzamide

InChi Key: AMXJMRXFZPRCQM-UHFFFAOYSA-N

InChi Code: InChI=1S/C25H32BrFN4O2/c1-3-31-13-11-17(12-14-31)16-29-25(28)30-24(32)21-5-4-6-22(27)20(21)9-7-18-15-19(26)8-10-23(18)33-2/h4-6,8,10,15,17H,3,7,9,11-14,16H2,1-2H3,(H3,28,29,30,32)

SMILES Code: O=C(NC(NCC1CCN(CC)CC1)=N)C2=CC=CC(F)=C2CCC3=CC(Br)=CC=C3OC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 519.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Sayre EC, Guermazi A, Esdaile JM, Kopec JA, Singer J, Thorne A, Nicolaou S, Cibere J. Associations between MRI features versus knee pain severity and progression: Data from the Vancouver Longitudinal Study of Early Knee Osteoarthritis. PLoS One. 2017 May 4;12(5):e0176833. doi: 10.1371/journal.pone.0176833. eCollection 2017. PubMed PMID: 28472071; PubMed Central PMCID: PMC5417516.

2: Yang H, Wahlmüller FC, Sarg B, Furtmüller M, Geiger M. A+-helix of protein C inhibitor (PCI) is a cell-penetrating peptide that mediates cell membrane permeation of PCI. J Biol Chem. 2015 Jan 30;290(5):3081-91. doi: 10.1074/jbc.M114.581736. Epub 2014 Dec 8. PubMed PMID: 25488662; PubMed Central PMCID: PMC4317013.

3: Stoeber J, Kobori O, Brown A. Perfectionism cognitions are multidimensional: a reply to Flett and Hewitt (2014). Assessment. 2014 Dec;21(6):666-8. doi: 10.1177/1073191114550676. Epub 2014 Sep 14. PubMed PMID: 25225230.

4: Yi F, Moon I, Lee YH. A multispectral photon-counting double random phase encoding scheme for image authentication. Sensors (Basel). 2014 May 20;14(5):8877-94. doi: 10.3390/s140508877. PubMed PMID: 24854208; PubMed Central PMCID: PMC4063078.

5: Stoeber J, Kobori O, Brown A. Examining mutual suppression effects in the assessment of perfectionism cognitions: evidence supporting multidimensional assessment. Assessment. 2014 Dec;21(6):647-60. doi: 10.1177/1073191114534884. Epub 2014 May 15. PubMed PMID: 24830512.

6: Wang XH, Wang HM, Zhao BL, Yu P, Fan ZC. Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17. J Mol Endocrinol. 2014 Aug;53(1):17-29. doi: 10.1530/JME-14-0005. Epub 2014 Apr 29. PubMed PMID: 24780838.

7: Bruyère O, Reginster JY, Bellamy N, Chapurlat R, Richette P, Cooper C; SEKOIA investigators. Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis. Rheumatology (Oxford). 2014 Aug;53(8):1457-64. doi: 10.1093/rheumatology/keu018. Epub 2014 Mar 25. PubMed PMID: 24667161.

8: Jaguszewski M, Radovanovic D, Nallamothu BK, Lüscher TF, Urban P, Eberli FR, Bertel O, Pedrazzini GB, Windecker S, Jeger R, Erne P; AMIS Plus Investigators. Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse? EuroIntervention. 2013 Dec;9(8):909-15. doi: 10.4244/EIJV9I8A153. PubMed PMID: 24384288.

9: Wang H, Li C, Wang L, Yang Z, Cao K. Initial experience with a magnetic navigation system for invasive treatment in patients with non-ST-segment elevation acute coronary syndromes. J Interv Cardiol. 2011 Dec;24(6):549-54. doi: 10.1111/j.1540-8183.2011.00673.x. Epub 2011 Aug 25. PubMed PMID: 21883473.

10: Simsek C, Magro M, Patterson MS, Onuma Y, Ciampichetti I, van Weenen S, van Domburg RT, Serruys PW, Boersma E, van Geuns RJ. Magnetic navigation system assisted stenting of coronary bifurcation lesions. EuroIntervention. 2011 Mar;6(8):970-6. doi: 10.4244/EIJV6I8A168. PubMed PMID: 21330245.

11: Patterson MS, Dirksen MT, Ijsselmuiden AJ, Amoroso G, Slagboom T, Laarman GJ, Schultz C, van Domburg RT, Serruys PW, Kiemeneij F. Primary percutaneous coronary intervention by magnetic navigation compared with conventional wire technique. Eur Heart J. 2011 Jun;32(12):1472-8. doi: 10.1093/eurheartj/ehp587. Epub 2010 Jan 4. PubMed PMID: 20051425.

12: Stoeber J, Kobori O, Tanno Y. The Multidimensional Perfectionism Cognitions Inventory-English (MPCI-E): reliability, validity, and relationships with positive and negative affect. J Pers Assess. 2010 Jan;92(1):16-25. doi: 10.1080/00223890903379159. PubMed PMID: 20013452.

13: Patterson MS, van Nooijen F, Ijsselmuiden A, Dirksen M, Van Domburg R, Serruys P, Kiemeneij F. Comparison of magnetically navigated and conventional wire percutaneous coronary intervention of a single discrete stenosis. Catheter Cardiovasc Interv. 2009 Nov 1;74(5):693-9. doi: 10.1002/ccd.22117. PubMed PMID: 19496121.

14: Mazor K, Clauser BE, Holtman M, Margolis MJ. Evaluation of missing data in an assessment of professional behaviors. Acad Med. 2007 Oct;82(10 Suppl):S44-7. PubMed PMID: 17895689.

15: Love JA, Benson J. Community use of a pushrim activated power-assisted wheelchair by an individual with facioscapulohumeral muscular dystrophy. Physiother Theory Pract. 2006 Sep;22(4):207-18. PubMed PMID: 16920679.

16: Kamath CC, Kremers HM, Vanness DJ, O'Fallon WM, Cabanela RL, Gabriel SE. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value Health. 2003 Mar-Apr;6(2):144-57. PubMed PMID: 12641865.

17: Vecellio None L, Grimbert D, Becquemin MH, Boissinot E, Le Pape A, Lemarié E, Diot P. Validation of laser diffraction method as a substitute for cascade impaction in the European Project for a Nebulizer Standard. J Aerosol Med. 2001 Spring;14(1):107-14. PubMed PMID: 11495481.

18: Kwong WT, Ho SL, Coates AL. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor. J Aerosol Med. 2000 Winter;13(4):303-14. PubMed PMID: 11262437.

19: Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol. 2000 Nov;27(11):2635-41. PubMed PMID: 11093446.

20: Moncayo J, Devuyst G, Van Melle G, Bogousslavsky J. Coexisting causes of ischemic stroke. Arch Neurol. 2000 Aug;57(8):1139-44. PubMed PMID: 10927793.